Atovaquone (Page 4 of 4)

16 HOW SUPPLIED/STORAGE AND HANDLING

Atovaquone oral suspension, USP is a yellow homogenous suspension containing 750 mg atovaquone USP per 5 mL.

18 cups x 5 mL (750 mg/ 5mL), NDC 0904-7064-25

42 cups x 5 mL (750 mg/ 5mL), NDC 0904-7064-53

Store at 15° to 25°C (59° to 77°F). Do not freeze. Dispense in tight container as defined in USP.

17 PATIENT COUNSELING INFORMATION

Administration Instructions
Instruct patients to:
• Ensure the prescribed dose of atovaquone oral suspension is taken as directed.
• Take their daily doses of atovaquone oral suspension with food, as food will significantly improve the absorption of the drug.
• Shake atovaquone oral suspension gently before use each time.

address1

Manufactured for:
Camber Pharmaceuticals, Inc.
Piscataway, NJ 08854
By: HETEROTM
HETERO LABS LIMITED 204961
Jeedimetla, Hyderabad – 500 055, India. Distributed By:

MAJOR® PHARMACEUTICALS

17177 N Laurel Park Dr., Suite 233

Livonia, MI 48152

Revised: June 2018

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

Atovaquone Oral Suspension, USP

750 mg/5mL

cup label
(click image for full-size original)
ATOVAQUONE atovaquone suspension
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0904-7064(NDC:31722-629)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ATOVAQUONE (ATOVAQUONE) ATOVAQUONE 750 mg in 5 mL
Inactive Ingredients
Ingredient Name Strength
BENZYL ALCOHOL
XANTHAN GUM
POLOXAMER 188
WATER
HYPROMELLOSE 2910 (3 MPA.S)
SACCHARIN SODIUM
Product Characteristics
Color YELLOW Score
Shape Size
Flavor STRAWBERRY Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0904-7064-25 18 CUP in 1 CARTON contains a CUP (0904-7064-41)
1 NDC:0904-7064-41 5 mL in 1 CUP This package is contained within the CARTON (0904-7064-25)
2 NDC:0904-7064-53 42 CUP in 1 CASE contains a CUP (0904-7064-41)
2 NDC:0904-7064-41 5 mL in 1 CUP This package is contained within the CASE (0904-7064-53)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA210692 10/11/2018
Labeler — Major Pharmaceuticals (191427277)

Revised: 12/2020 Major Pharmaceuticals

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.